Joi Dunbar

992 total citations
23 papers, 590 citations indexed

About

Joi Dunbar is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Joi Dunbar has authored 23 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Joi Dunbar's work include Chronic Lymphocytic Leukemia Research (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Opioid Use Disorder Treatment (3 papers). Joi Dunbar is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Opioid Use Disorder Treatment (3 papers). Joi Dunbar collaborates with scholars based in United States, United Kingdom and Ireland. Joi Dunbar's co-authors include Ryan Z. Turncliff, Bernard L. Silverman, Kenneth C. Lasseter, Elliot Ehrich, Qunming Dong, Robert W. Ross, L. Kerrie, Glen J. Weiss, Scott Gettinger and William H. Sharfman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Joi Dunbar

23 papers receiving 572 citations

Peers

Joi Dunbar

ONCOL

PFM

EPIDE

GENET

Ahmed Aribi United States

Vreni Schneider Switzerland

Mary Beth Tombes United States

Yisong Wang China

Shelly Tartakover Matalon Israel

Mariola Sadowska United States

Ashis Mukhopadhyay India

Mahyar Ostadkarampour Sweden

Laurie B. Griffin United States

Timothy S. Collins United States

Ahmed Aribi United States

Joi Dunbar

382 ×1.2

211 ×2.1

ONCOL

97 ×1.0

PFM

63 ×0.7

EPIDE

202 ×2.3

GENET

Citations per year, relative to Joi Dunbar Joi Dunbar (= 1×) peers Ahmed Aribi

Countries citing papers authored by Joi Dunbar

Since Specialization

Citations

This map shows the geographic impact of Joi Dunbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joi Dunbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joi Dunbar more than expected).

Fields of papers citing papers by Joi Dunbar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joi Dunbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joi Dunbar. The network helps show where Joi Dunbar may publish in the future.

Co-authorship network of co-authors of Joi Dunbar

This figure shows the co-authorship network connecting the top 25 collaborators of Joi Dunbar. A scholar is included among the top collaborators of Joi Dunbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joi Dunbar. Joi Dunbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dunbar, Joi, et al.. (2024). Effects of zuranolone on next-day simulated driving in healthy adults. Psychopharmacology. 242(2). 389–400. 1 indexed citations

Dunbar, Joi, David P. Walling, Rakesh K. Jain, et al.. (2024). Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial. Journal of Psychopharmacology. 38(12). 1122–1136. 1 indexed citations

Deligiannidis, Kristina M., Amy Bullock, Indrani Nandy, et al.. (2024). Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals. Journal of Clinical Psychopharmacology. 44(4). 337–344. 3 indexed citations

Dunbar, Joi, Mark Versavel, Yuan Zhao, et al.. (2019). Evaluation of the Pharmacokinetic Interaction Between the Voltage‐ and Use‐Dependent Nav1.7 Channel Blocker Vixotrigine and Carbamazepine in Healthy Volunteers. Clinical Pharmacology in Drug Development. 9(1). 62–73. 10 indexed citations

Woodward, Caroline, Himanshu Naik, Mark Versavel, et al.. (2018). Phase 1 study to evaluate the absorption, metabolism and excretion of the NAV1.7-selective sodium channel blocker BIIB074. Drug Metabolism and Pharmacokinetics. 33(1). S74–S74. 4 indexed citations

Wagner, Andrew J., Rashmi Chugh, Lee S. Rosen, et al.. (2013). A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas. Clinical Cancer Research. 19(21). 6020–6029. 67 indexed citations

Horwitz, Steven M., Ian W. Flinn, Manish R. Patel, et al.. (2013). Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with relapsed/refractory lymphoma.. Journal of Clinical Oncology. 31(15_suppl). 8518–8518. 17 indexed citations

Flinn, Ian W., Manish R. Patel, Brad S. Kahl, et al.. (2013). Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood. 122(21). 677–677. 26 indexed citations

Jimeno, Antonio, Glen J. Weiss, Wilson H. Miller, et al.. (2013). Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors. Clinical Cancer Research. 19(10). 2766–2774. 143 indexed citations

10.

Siegel, David, Sundar Jagannath, David H. Vesole, et al.. (2011). A phase 1 study of IPI-504 (retaspimycin hydrochloride) in patients with relapsed or relapsed and refractory multiple myeloma. Leukemia & lymphoma. 52(12). 2308–2315. 23 indexed citations

11.

Oh, William, Matthew D. Galsky, Walter M. Stadler, et al.. (2011). Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer. Urology. 78(3). 626–630. 59 indexed citations

12.

Senzer, Neil, David S. Mendelson, Colin D. Weekes, et al.. (2011). Abstract B101: Safety, tolerability, and pharmacokinetics of IPI-493, an oral Hsp90 inhibitor, in patients with advanced cancers.. Molecular Cancer Therapeutics. 10(11_Supplement). B101–B101. 2 indexed citations

13.

Riely, Gregory J., Scott Gettinger, N. Gabrail, et al.. (2011). Safety and activity of IPI-504 (retaspimycin hydrochloride) and docetaxel in pretreated patients (pts) with metastatic non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). 7516–7516. 8 indexed citations

14.

Riely, Gregory J., Merrill J. Egorin, David B. Solit, et al.. (2009). A phase Ib trial of IPI-504 (retaspimycin hydrochloride), a novel Hsp90 inhibitor, in combination with docetaxel. Journal of Clinical Oncology. 27(15_suppl). 3547–3547. 6 indexed citations

15.

Dunbar, Joi, et al.. (2007). Population Pharmacokinetics of Extended-Release Injectable Naltrexone (XR-NTX) in Patients With Alcohol Dependence. Journal of Studies on Alcohol and Drugs. 68(6). 862–870. 17 indexed citations

16.

Dunbar, Joi, Ryan Z. Turncliff, Qunming Dong, et al.. (2006). Single‐ and Multiple‐Dose Pharmacokinetics of Long‐acting Injectable Naltrexone. Alcoholism Clinical and Experimental Research. 30(3). 480–490. 94 indexed citations

17.

Turncliff, Ryan Z., Joi Dunbar, Qunming Dong, et al.. (2005). Pharmacokinetics of Long‐Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment. The Journal of Clinical Pharmacology. 45(11). 1259–1267. 24 indexed citations

18.

Turncliff, Ryan Z., et al.. (2005). Single and multiple dose pharmacokinetics of long-acting injectable naltrexone. Clinical Pharmacology & Therapeutics. 77(2). P42–P42. 5 indexed citations

19.

Dunbar, Joi, Ari Illeperuma, Jasmina Milovanović, et al.. (2004). A placebo- and active comparator-controlled dose escalation study of the pharmacokinetics, pharmacodynamics, and safety of inhaled large porous particle (AIR®) epinephrine in normal volunteers. Journal of Allergy and Clinical Immunology. 113(2). S260–S260. 6 indexed citations

20.

Chambers, Scott, Joi Dunbar, & Barry Taylor. (1980). Inhaled powder compared with aerosol administration of fenoterol in asthmatic children.. Archives of Disease in Childhood. 55(1). 73–74. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact